Rapidly Spreading Ebola Outbreak in DRC and Uganda Passes 1,100 Cases as Global Health Authorities Respond

Rapidly Spreading Ebola Outbreak in DRC and Uganda Raises Global Health Concerns

The Democratic Republic of the Congo (DRC) and neighboring Uganda are facing one of the most serious Ebola outbreaks in history, with confirmed cases now exceeding 1,100 and a growing death toll that has health authorities scrambling to contain the virus. As of late June 2026, this outbreak – caused by the rarer Bundibugyo virus species – has become the second-largest Ebola outbreak ever recorded and the largest ever caused by this particular strain.

Current Situation: A Rapidly Escalating Crisis

According to the latest data from the DRC Ministry of Health, more than 1,118 confirmed cases have been reported as of June 23, 2026, including 291 confirmed deaths. The U.S. Centers for Disease Control and Prevention (CDC) reports that cases have risen faster in this outbreak than any other Ebola outbreak to date. The outbreak is also now affecting Uganda, where 20 confirmed cases and two deaths have been reported.

The epicenter remains Ituri Province in northeastern DRC, which accounts for 91% of all confirmed cases. Within Ituri, the hardest-hit health zones include Bunia (247 cases), Rwampara (195 cases), and Mongbwalu (189 cases) – a gold-mining town of approximately 130,000 people where the outbreak is believed to have originated.

Cases have also been confirmed in North Kivu and South Kivu provinces, and the virus has demonstrated an alarming capacity for geographic spread. In Uganda, cases have been reported in Kampala, the capital city, and the neighboring district of Wakiso – densely populated urban areas that present unique challenges for containment.

A Different Virus: Understanding Bundibugyo

This outbreak is caused by the Bundibugyo virus (Bundibugyo virus disease, or BVD), one of four orthoebolavirus species known to cause Ebola disease in humans. Unlike the more well-known Zaire ebolavirus (which caused the devastating 2014-2016 West Africa outbreak), Bundibugyo has only caused two prior outbreaks – one in Uganda in 2007 and one in DRC in 2012 – with case fatality rates of 32% and 55% respectively.

In the current outbreak, the case fatality rate stands at approximately 26%, though health officials caution this figure may be an underestimate. Many deaths that occurred before the outbreak was officially declared remain under investigation.

A critical distinction of this outbreak is that there is no approved vaccine for the Bundibugyo virus. Existing Ebola vaccines target the Zaire species and do not provide protection against Bundibugyo. Treatment currently consists of supportive care, including fluid replacement, oxygen therapy, and management of specific symptoms.

How the Outbreak Began

According to reports from NPR and the World Health Organization, the first suspected case involved a nurse who developed fever and vomiting on April 24, 2026. She died in Bunia but was buried in the gold-mining town of Mongbwalu. In early May, four healthcare workers in Mongbwalu died within just four days, triggering alarm.

Initial testing at Congo’s National Institute for Biomedical Research came back negative because scientists screened for the Zaire and Sudan species of the virus. It was not until May 15 that genomic sequencing confirmed the rarer Bundibugyo species was circulating – by which point more than 50 people had already died in the Shuni neighborhood of Mongbwalu alone.

The delay in identification had serious consequences. Caused by a species that is harder to detect with standard tests, the virus had weeks of undetected transmission during which it spread unchecked across multiple provinces.

Why the Outbreak is Spreading So Fast

Several factors are contributing to the rapid spread of this outbreak:

• Gold mining mobility: Eastern Congo’s artisanal gold mines draw a highly mobile workforce from across the region. Miners work in close proximity and frequently travel between mining sites and their home communities, carrying the virus with them.
• Complex humanitarian environment: The affected region has been devastated by decades of armed conflict. Mobile and displaced populations, overcrowded camps, and limited access to basic services create ideal conditions for viral transmission.
• Community mistrust: Deep-seated suspicion of health responders has hampered containment efforts. Some community members believe aid groups are spreading the disease. Resistance to safe burial practices has led to confrontations, including incidents where police had to fire warning shots to disperse crowds.
• Healthcare worker infections: Multiple healthcare workers have been infected, and the ECDC notes that transmission has been amplified in healthcare settings where infection prevention measures are inadequate.
• Security challenges: Increasing security-related incidents affecting health facilities have constrained access for response teams and disrupted surveillance activities.

International Response and Risk Assessment

The World Health Organization (WHO) is coordinating with national authorities in both DRC and Uganda, alongside international partners, implementing an extensive set of response measures. A regional preparedness and prioritization framework continues to guide readiness activities across the African region.

The CDC has issued Travel Health Notices for both DRC and Uganda, recommending against non-essential travel to Ituri, North Kivu, and South Kivu provinces. Enhanced travel screening measures have been implemented at four designated U.S. airports – Washington-Dulles, Atlanta Hartsfield-Jackson, Houston George Bush Intercontinental, and New York JFK – for passengers arriving from DRC, Uganda, and South Sudan.

Despite the severity of the outbreak in Africa, U.S. health officials assess the risk to the American public as low. The European Centre for Disease Prevention and Control (ECDC) similarly assesses the likelihood of infection for people living in the EU/EEA as very low.

So far, two imported cases have been reported outside Africa: one confirmed case in France involving a humanitarian doctor who returned from DRC, and one U.S. citizen who was medically evacuated to Germany for treatment in May.

What Travelers Need to Know

The CDC advises travelers to affected areas to take the following precautions:

• Avoid non-essential travel to Ituri, North Kivu, and South Kivu provinces in DRC
• Practice strict hygiene, including frequent hand washing with soap and water or using alcohol-based hand sanitizer
• Avoid contact with blood and bodily fluids of anyone who is ill
• Avoid handling items that may have come in contact with an infected person
• Avoid participating in funeral or burial practices that involve touching the body of someone who died from suspected Ebola
• Avoid contact with bats, non-human primates, and raw or undercooked bushmeat
• Monitor for symptoms for 21 days after leaving affected areas

Frequently Asked Questions About Ebola (Bundibugyo Virus)

What is Bundibugyo virus?

Bundibugyo virus is one of four species of orthoebolavirus that cause Ebola disease in humans. It was first identified during an outbreak in Uganda’s Bundibugyo district in 2007. It is generally considered less lethal than Zaire ebolavirus but still carries a significant mortality risk.

How is Ebola transmitted?

Ebola spreads through direct contact with the blood, secretions, organs, or other bodily fluids of infected individuals. It can also spread through contact with contaminated surfaces or materials. Fruit bats are suspected to be the natural reservoir, and human infection is thought to occur through close contact with infected wildlife.

What are the symptoms?

Symptoms typically appear 2 to 21 days after exposure and include fever, severe headache, vomiting, diarrhea, abdominal pain, muscle pain, severe weakness, and in some cases unexplained bleeding (nosebleeds, vomiting blood). Individuals are not infectious until symptoms develop.

Is there a treatment or vaccine?

There is currently no licensed vaccine for Bundibugyo virus. Treatment consists of supportive care – managing symptoms, maintaining fluid and electrolyte balance, and treating any secondary infections. Experimental therapies may be available through clinical trials.

Should I be worried about a global pandemic?

International health authorities including the WHO, CDC, and ECDC assess the risk of widespread global transmission as very low. Ebola is less transmissible than respiratory viruses like influenza or COVID-19 because it requires direct contact with bodily fluids. Strong public health systems in developed countries are well-positioned to contain any imported cases.

Conclusion

The ongoing Ebola outbreak in the DRC and Uganda represents a major public health emergency that demands urgent attention and resources. With cases rising faster than any previous Ebola outbreak and no approved vaccine available for the causative strain, the window for effective containment is narrowing. The international community must act swiftly to support local response efforts, strengthen disease surveillance, and address the underlying factors – including conflict, poverty, and community mistrust – that allow the virus to spread.